chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sleeps 18 hours day; Achy; Blochy red arm; Extreme fatigue; Chills; Very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Sleeps 18 hours day), PAIN (Achy), INJECTION SITE ERYTHEMA (Blochy red arm), FATIGUE (Extreme fatigue) and CHILLS (Chills) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced HYPERSOMNIA (Sleeps 18 hours day), PAIN (Achy), INJECTION SITE ERYTHEMA (Blochy red arm), FATIGUE (Extreme fatigue), CHILLS (Chills) and HEADACHE (Very bad headache). At the time of the report, HYPERSOMNIA (Sleeps 18 hours day), PAIN (Achy), FATIGUE (Extreme fatigue), CHILLS (Chills) and HEADACHE (Very bad headache) outcome was unknown and INJECTION SITE ERYTHEMA (Blochy red arm) had not resolved.            No Concomitant product use was reported. No treatment information was provided.  The patient received their Moderna COVID-19 Booster shot on 28-Oct-2021 and experienced extreme fatigue and was sleeping 18 hours day. Th patient also developed chills, achy and had very bad headache. Reportedly, the patient was still having blotchy arm below the injection site and it was red but doesn't hurt or itch.  Patient does not have any underlying conditions and was not taking any medications and was not allergic.  Company comment: This is a spontaneous  case concerning a 80-year-old male patient with no relevant medical history, who experienced the non-serious  unexpected events Hypersomnia and Pain and expected injection site erythema, fatigue, chills and headache . The events occurred after the third (booster) dose of mRNA-1273 Moderna vaccine on an unknown date.  The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.; Sender's Comments: This is a spontaneous  case concerning a 80-year-old male patient with no relavant medical history, who experienced the non-serious  unexpected events Hypersonmnia and Pain and expected injection site erythema, fatigue, chills and headache . The events occurred after the third (booster) dose of mRNA-1273 Moderna vaccine on an unknown date.  The benefit-risk relationship of mRNA-1273 Moderna vaccine is not affected by this report.
Vaccine was expired on 09-Nov-2021 and administered on 10-Nov-2021/administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-Nov-2021 and administered on 10-Nov-2021/administer expired vaccine to patients, after the manufacture date of expiration) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-Nov-2021 and administered on 10-Nov-2021/administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 09-Nov-2021 and administered on 10-Nov-2021/administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 168 doses.  The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Non significant live follow-up: Additional reporter added.
Numbness; Tingling in hand, feet, and legs and arms./like little pins and needs like nerve problems/needle pain; keep going to the bathroom, urinating; Extreme itching under arms and all the crevice areas on body; >than 35 days since first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling in hand, feet, and legs and arms./like little pins and needs like nerve problems/needle pain), POLLAKIURIA (keep going to the bathroom, urinating), PRURITUS (Extreme itching under arms and all the crevice areas on body) and PRODUCT DOSE OMISSION ISSUE (>than 35 days since first dose) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness), PARAESTHESIA (Tingling in hand, feet, and legs and arms./like little pins and needs like nerve problems/needle pain), POLLAKIURIA (keep going to the bathroom, urinating), PRURITUS (Extreme itching under arms and all the crevice areas on body) and PRODUCT DOSE OMISSION ISSUE (>than 35 days since first dose). At the time of the report, HYPOAESTHESIA (Numbness) and PARAESTHESIA (Tingling in hand, feet, and legs and arms./like little pins and needs like nerve problems/needle pain) had not resolved, POLLAKIURIA (keep going to the bathroom, urinating) outcome was unknown and PRURITUS (Extreme itching under arms and all the crevice areas on body) and PRODUCT DOSE OMISSION ISSUE (>than 35 days since first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.  Laboratory information included test for sugar and the results were normal.  Patient states that she was doing research to find out whether she was having Guillen-Barre disease.
about an hour after the shot it swale up very bad, had a bad allergic reaction, had a red mark across  her neck
3 days after receiving the vaccination, patient broke out in an itchy bumpy rash on her chest/back/neck. It lasted a few days then seemed to be resolving, but returned and is still present. Husband had the same reaction to the same vaccine.
This is a 35-year-old male who received his first anthrax vaccination on March 8, 2003. On that day, he also received smallpox, influenza, and had a PPD placed. He reports that approximately one-and-one-half weeks later he developed left sided body pain from his shoulder to his left leg. He remembers his left leg being stiff, numb, and painful. He reports that symptoms in his arm improved after awhile; he estimates the improvement was around April 28th when he deployed. The leg symptoms continued. He reports that the leg pain and numbness was felt mostly in the posterior thigh and the lateral part of the thigh and calf. This pain is some times sharp, however, at times has been dull. The pain also increases with an increase in activity. At this time, he reports that the leg pain occurs several times a day. This pain also awakens him from sleep at times. He returned from deployment on August 12, 2003 and was seen for evaluation. He is currently on Vioxx 25MG every day.
1/15/22 6:30AM: Injection site is feeling much better, nausea and headache have cleared up. I felt good until I looked in the mirror and saw that I was swollen under my eyes. Researched to find multiple reports of hyaluronic acid soft tissue filler delayed inflammatory reactions following COVID-19 vaccination.  I had a Hyaluronic acid-type dermal filler injected in my tear troughs on 10/26/21 and more in my tear troughs as well as upper lip on 12/7/21 (my lip has not appreciably swelled after the booster---yet).
I had sweats, aches, chills, loss sense of smell, headache, diarrhea, cough, difficulty breathing, congestion, and extreme fatigue. I tested positive for COVID-19 at home. I talked to a doctor through telehealth, and they recommended me to go to urgent care. They did a chest x-ray and exam. I was prescribed albuterol which helped with breathing. I still have fatigue and brain fog.
Pt states that the evening she received vaccine her arm became painful and that she has been experiencing pain/weakness ever since.
Ringing in ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in ears) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in ears). At the time of the report, TINNITUS (Ringing in ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
5 days after receiving her vaccines (9/24)she began to "not walk well."  On the morning of the 25th she refused to walk and seemed to be having left hip pain. There was no history of injury, fever, nor previous illness. I saw her in the afternoon. Initially she was asleep in Mom's arms. Her lower extremities had full range of motion without any discomfort, and no tenderness to palpation. When she was awakened she was a bit fussy, calming as she came fully awake. Again, on exam, she had full range of motion without pain. When placed on her feet, she cried but was able to walk. Per Mom, this was much better than she had been earlier. Her clinical picture was highly suggestive of toxic synovitis or minor trauma. No tests were performed, and I had her come back the next day (9/26). She is totally fine, running around the room, climbing on the chairs, etc. Her lower extremity exam is totally normal. The picture suggests post-vaccine toxic synovitis, as I do not have any other explanation.
Patient developed swelling, itching, redness, hardness, and hot to touch around injection site. Area of reaction measured 90mm wide and 90 mm in length.
On 2/19 patient started slurring words so they called 911. Patient taken to ER Hospital and was admitted for 4 days. The CAT scan was normal and did not show a stroke. Patient did not receive a diagnosis although sent home with TIA instructions. Patient does not remember anything from Tuesday through Thursday night. Patient was prescribed Plavix at hospital in case it was a stroke. Patient also taking Aspirin but not Benicar. This week patient was too weak to go to the doctor but has appt for next week. Mental has come back but physical is weak.
N, Vomiting, fever, chills, body aches everywhere, headache, unable to sleep
Dose number=3 date=01Nov2021; COVID 19 Treatment; Dose number=3 date=01Nov2021; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Nov2021 at 13:00 as dose 3 (booster), single (Lot number: FF2593) at the age of 28 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Depression" (unspecified if ongoing); "ADHD" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION, start date: Jan2021, stop date: May2022. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 30Apr2022, outcome "unknown", COVID-19 (medically significant) with onset 30Apr2022, outcome "not recovered" and all described as "Dose number=3 date=01Nov2021; COVID 19 Treatment". The patient received other medication Bupropion in 2 weeks. First positive test/onset of symptoms was 30Apr2022. First dose of Paxlovid as treatment of COVID-19 taken 30Apr2022 in the evening. Last dose taken on 05May2022 in the morning. Negative at home antigen test result received on 06May2022. Rebound of covid viral load occurred on day 3 after completing Paxlovid treatment. Positive antigen test result received on 08May2022 11:00 am. Confirmed with 2 at home antigen tests. Rebound happened on day 8 of Covid (starting from first positive test date). The patient was recovering and no treatment was reported. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Apr2022) Positive; (06May2022) Negative; (08May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
1 hour after the vaccine shot I began experiencing allergic symptoms including intense drowsiness, throat scratching, coughing, lip and tongue swelling. I took a Zyrtec and the symptoms began improving. They did not fully go away until 4 hours later.
Intestinal cramps; urgency to go to the bathroom/the urgency is almost like diarrhea; nausea; sore arm; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored Program. A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231, expiration date 30Apr2021) on her left deltoid, intramuscular on 14Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported by the patient that she is having intestinal cramps since last night. The patient also said that she is also experiencing nausea, urgency to go to the bathroom (the urgency is most likely diarrhea), and she has a sore arm; all on 14Jan2021. The outcome of the events was not recovered.
Around 11:30 pm that evening I started feeling extremely warm in my face and thighs. Figuring it was due to the shot, I decide to try and lay down to sleep it off. A short time later, I awoke freezing with chills and uncontrollable shivering. My whole body hurt especially my lower back and pressure in my head. This continued throughout the night until the early morning. As the shivering and chills subsided, extreme fatigue, body aches and head pressure continued and it was difficult to get up at points. I had no appetite and forced myself to drink to stay hydrated.  About 1:00 pm, I started to feel better, but that was short lived. Approximately 4:30 ? 5pm, the chills and shivering returned and I had 101 fever. I had some tea and toast and then went to bed for the night. When I awoke this morning, I felt a million times better. As of writing this email, I still have some slight fatigue, aches, and head pressure, but night and day difference from yesterday.
My lymph node in my right armpit has swelled immensely and is severely painful; My lymph node in my right armpit has swelled immensely and is severely painful; fatigue is moderate; the muscle of the injection site is moderately sore; This is a spontaneous report received from a contactable reporter. The reporter is the patient.  A 23-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Feb2022 (Lot number: FJ6369) at the age of 23 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8735, Location of injection: Arm Right), administration date: 26Apr2021, when the patient was 23 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733, Location of injection: Arm Right), administration date: 06Apr2021, when the patient was 23 years old, for COVID-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset 06Feb2022, outcome "recovering" and all described as "My lymph node in my right armpit has swelled immensely and is severely painful"; FATIGUE (non-serious) with onset 06Feb2022, outcome "recovering", described as "fatigue is moderate"; VACCINATION SITE PAIN (non-serious) with onset 06Feb2022, outcome "recovering", described as "the muscle of the injection site is moderately sore". Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, fatigue, vaccination site pain. Additional information included a covid tested post vaccination was not performed and since the vaccination, the patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Above clavicle of left side it started to swell and lymph node was tender and swollen for 2 days. Tenderness stopped but is still enlarged as of today, 3/6/2021
Had Varicella vaccine 11/16/15 in RUE - felt a little bit of pain during the night and it was worse in the morning. Noticed it was swollen, red, and more painful at injection site. No drainage or streaking. Taking Advil with some improvement in discomfort. Denies fever/chills. Denies lip swelling, hives, rash sob/doe, nausea, vomiting, diarrhea or other symptoms.
Pale, weak, cold and clammy. Vaccine given at 4:15. Symptoms developed 5-10 minutes after vaccine was administered.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent conditions, historical conditions or concomitant therapies were reported. On 26-JUN-2016, the patient was vaccinated with improperly stored M-M-R II (albumin status: rHA, lot # L024265, expiration date 01-JUL-2017, route of administration not provided). The vaccine was stored in an improper temperature of 50.8F for a cumulative period of 38 hours. The temperature excursion was captured by digital data logger. No adverse effects were reported. Additional information has been requested. This is one of the several reports received from the same reporter.
All I got was pain on my left arm, the pain will go down my lower arm and down my fingers. It was hard to move my arm and my fingers, It lasted a few months because I just realized I haven't had this pain in a few weeks, I'm guessing the pain lasted till August. I was going to Chiropractic for some adjustments prior to the vaccination, I told him about the pain and asked if I needed an adjustment. He recommended me to see my Primary Doctor and she thought it was due to the injection hitting my nerve. She determined that if it lasted longer she would refer me for an X-ray which We did not have to.
Fine itchy trash on back,  arms, trunk,  face.  No difficulty breathing or swelling of tongue or throat.  Treated with typical OTC anti itch spray, and benadryl and zyrtec
It started out like a cold, I had a cough, fatigue, that progressed to feeling more like the flu. I started having body aches and was more lethargic. I used home COVID-19 test that came back positive. I called my doctor's office to have a telehealth visit. We discussed my positive COVID-19 result, symptoms. I was prescribed the PAXLOVID the next day. Once starting the medication, it was very hard on my system, it made me vomit. I was extremely miserable taking the PAXLOVID with how it made me feel the whole time.
Fever 101-102, myalgias, swelling, redness moderate 8 cm diameter both deltoid for 5 days following immunization.
This patient went to his vascular doctor on 5-10-21 and a clot was discovered on the groin area of the left leg.  The MD said it did not warrant going to the ER.  He has 2 stents in the right leg, (1 in thigh and 1 in calf).  Patient reported it being uncomfortable but not "painful".  Md placed him on Eliquis 10 mg, BID  for 7 days then reducing the dose to 5 mg BID thereafter for about 5 months/
6 hrs after receiving shot severe chills, nausea and aching with temp 103 which resolved in 12-18 hrs
She received the shot the morning of 3/16/2021 at 830am. Starting about 9pm on 3/16/2021 her face started tingling.  By 3am her face had started swelling on the left side. She took benadryl. By 9am on 3/17/2021 the left side of her face neck and lips was severely swollen from the cheekbone down to her throat.  I took her to the emergency room. In the emergency room of on 3/17/2021 she was given benadryl, a steroid and pepcid through an IV.  By the time we had been in the ER for an hour her tongue began to swell on the same side.  The hospital admitted her overnight for observation because of concerns about the swelling in her tongue and throat. She was released from the hospital the next day and was prescribed a steroid and an antibiotic (doxycycline).
Flu like symptoms; Mild aching; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Mild aching) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 026A21A) for COVID-19 vaccination.     The patient's past medical history included Manic depression. Concurrent medical conditions included Lactose intolerant and Blood pressure high. Concomitant products included PAROXETINE, CHLORTALIDONE (CHLORTHALIDONE), IRBESARTAN, LEVOTHYROXINE, AMLODIPINE BESILATE (AMLODIPINE BESYLATE), CARBAMAZEPINE, METFORMIN, METOPROLOL SUCCINATE, PREGABALIN, ATORVASTATIN CALCIUM, QUETIAPINE FUMARATE (SEROQUEL) and CLONAZEPAM (KLONOPIN) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Mild aching). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and MYALGIA (Mild aching) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications also included an Over the Counter Flu-Like Medicine "name not provided".
I95.9 HYPOTENSION 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY R57.9 SHOCK, UNSPECIFIED 3/9/2022 NONTRAUMATIC ACUTE KIDNEY INJURY
Came to hospital for PVD needed vascular surgery and was swabbed for screening, asymptomaic. Pt discharged to alf